Cargando…

The oligomer modulator anle138b inhibits disease progression in a Parkinson mouse model even with treatment started after disease onset

Detalles Bibliográficos
Autores principales:	Levin, Johannes, Schmidt, Felix, Boehm, Cathrin, Prix, Catharina, Bötzel, Kai, Ryazanov, Sergey, Leonov, Andrei, Griesinger, Christian, Giese, Armin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2014
Materias:	Correspondence
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3984662/ https://www.ncbi.nlm.nih.gov/pubmed/24615514 http://dx.doi.org/10.1007/s00401-014-1265-3

Ejemplares similares

Anle138b: a novel oligomer modulator for disease-modifying therapy of neurodegenerative diseases such as prion and Parkinson’s disease
por: Wagner, Jens, et al.
Publicado: (2013)

Anle138b Partly Ameliorates Motor Deficits Despite Failure of Neuroprotection in a Model of Advanced Multiple System Atrophy
por: Fellner, Lisa, et al.
Publicado: (2016)

Anle138b modulates α‐synuclein oligomerization and prevents motor decline and neurodegeneration in a mouse model of multiple system atrophy
por: Heras‐Garvin, Antonio, et al.
Publicado: (2018)

The small molecule inhibitor anle145c thermodynamically traps human islet amyloid peptide in the form of non-cytotoxic oligomers
por: Saravanan, Manikam S., et al.
Publicado: (2019)

Reducing tau aggregates with anle138b delays disease progression in a mouse model of tauopathies
por: Wagner, Jens, et al.
Publicado: (2015)

The clinical drug candidate anle138b binds in a cavity of lipidic α-synuclein fibrils
por: Antonschmidt, Leif, et al.
Publicado: (2022)

Safety, tolerability and pharmacokinetics of the oligomer modulator anle138b with exposure levels sufficient for therapeutic efficacy in a murine Parkinson model: A randomised, double-blind, placebo-controlled phase 1a trial
por: Levin, Johannes, et al.
Publicado: (2022)

Targeting α-synuclein by PD03 AFFITOPE® and Anle138b rescues neurodegenerative pathology in a model of multiple system atrophy: clinical relevance
por: Lemos, Miguel, et al.
Publicado: (2020)

Late-stage Anle138b treatment ameliorates tau pathology and metabolic decline in a mouse model of human Alzheimer’s disease tau
por: Brendel, Matthias, et al.
Publicado: (2019)

The diphenylpyrazole compound anle138b blocks Aβ channels and rescues disease phenotypes in a mouse model for amyloid pathology
por: Martinez Hernandez, Ana, et al.
Publicado: (2017)

(11)C Radiolabeling of anle253b: a Putative PET Tracer for Parkinson's Disease That Binds to α‐Synuclein Fibrils in vitro and Crosses the Blood‐Brain Barrier
por: Maurer, Andreas, et al.
Publicado: (2020)

Iron-mediated aggregation and toxicity in a novel neuronal cell culture model with inducible alpha-synuclein expression
por: Bartels, Martin, et al.
Publicado: (2019)

Therapeutic Trial of anle138b in Mouse Models of Genetic Prion Disease
por: Vallabh, Sonia M., et al.
Publicado: (2023)

Single-Channel Electrophysiology Reveals a Distinct and Uniform Pore Complex Formed by α-Synuclein Oligomers in Lipid Membranes
por: Schmidt, Felix, et al.
Publicado: (2012)

In Silico Study of the Interactions of Anle138b Isomer, an Inhibitor of Amyloid Aggregation, with Partner Proteins
por: Kondratyev, Maxim S., et al.
Publicado: (2022)

Mechanism of action deconvolution of the small-molecule pathological tau aggregation inhibitor Anle138b
por: Hosseini-Gerami, Layla, et al.
Publicado: (2023)

Depopulation of dense α-synuclein aggregates is associated with rescue of dopamine neuron dysfunction and death in a new Parkinson’s disease model
por: Wegrzynowicz, Michal, et al.
Publicado: (2019)

Synthesis and Preliminary Characterization of Putative Anle138b-Centered PROTACs against α-Synuclein Aggregation
por: Pedrini, Martina, et al.
Publicado: (2023)

ANL/WSU radiation damage studies
por: Jankowski, D, et al.
Publicado: (1993)

Neutrino interactions at ANL, BNL, and CERN
por: Musset, P
Publicado: (1974)

[(11)C]MODAG-001—towards a PET tracer targeting α-synuclein aggregates
por: Kuebler, Laura, et al.
Publicado: (2020)

L'approche neurolinguistique (ANL) : foire aux questions /
por: Germain, Claude
Publicado: (2017)

Extended barrel module 0 instrumentation at ANL
por: ANL, group
Publicado: (1998)

AMU-ANL Conference on Direct Energy Conversion
por: Collective
Publicado: (1963)

Atlas Tile Calorimeter ANL master punching die
por: ANL, photos
Publicado: (1996)

Synergistic influence of phosphorylation and metal ions on tau oligomer formation and coaggregation with α-synuclein at the single molecule level
por: Nübling, Georg, et al.
Publicado: (2012)

ATLAS Tile calorimeter: ANL module0 submodules construction
por: ANL, photos
Publicado: (1999)

5th ANL/MSU/JINA/INT FRIB Workshop
por: Danielewicz, Pawel
Publicado: (2009)

Effects of pharmacological modulators of α-synuclein and tau aggregation and internalization
por: Dominguez-Meijide, Antonio, et al.
Publicado: (2020)

Does disease start in the mouth, the gut or both?
por: Prodan, Andrei, et al.
Publicado: (2019)

Modelling Ser129 Phosphorylation Inhibits Membrane Binding of Pore-Forming Alpha-Synuclein Oligomers
por: Nübling, Georg Sebastian, et al.
Publicado: (2014)

Comparison of LED and Cs Data Signals for the ANL Optical Test Module
por: Stanek, B, et al.
Publicado: (1999)

The ANL 50 MeV H$^{-}$ Injector: 35 Year Anniversary
por: Stipp, V F, et al.
Publicado: (1996)

Atlas Tile Calorimeter submodules assembly at ANL (Argonne National Lab)
por: Price, L
Publicado: (1999)

Guidelines for using the AMDLIB, IMSL, and NAG mathematical software libraries at ANL
por: Wang, J Y, et al.
Publicado: (1981)

6.6 Instrumentation for the ANL 12-ft Hydrogen Bubble Chamber
por: Simpson, J D
Publicado: (1967)

2.1 Status of ANL 12-ft Hydrogen Bubble Chamber
por: Pewitt, E G
Publicado: (1967)

The Superconducting Magnet Associated with the ANL 12-ft Hydrogen Bubble Chamber
por: Pewitt, E G
Publicado: (1967)

3rd ANL/MSU/INT/JINA RIA Theory Workshop
Publicado: (2006)

STOPP/START version 3: even better with age
por: Rochon, Paula A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_9ksg67unbvqo1iifpajaaftiq6